Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table

  1. Mach, F.
  2. Visseren, F.L.J.
  3. Cater, N.B.
  4. Salhi, N.
  5. Soronen, J.
  6. Ray, K.K.
  7. Delgado, V.
  8. Jukema, J.W.
  9. Laufs, U.
  10. Zamorano, J.-L.
  11. Ros, E.
  12. Plat, J.
  13. Gesztes, A.G.
  14. Tokgozoglu, L.
  15. Packard, C.
  16. Libby, P.
Revista:
Journal of Clinical Lipidology

ISSN: 1876-4789 1933-2874

Año de publicación: 2024

Tipo: Revisión

DOI: 10.1016/J.JACL.2024.07.001 GOOGLE SCHOLAR